Novo Nordisk Shares Slide After Trial Miss
CagriSema Falls Short of Expectations
Shares of Novo Nordisk dropped sharply after late-stage clinical trial results for its next-generation weight-loss drug, CagriSema, failed to meet...
Perplexity Shifts Toward Subscriptions
Startup Prioritizes Revenue Over Growth Metrics
Perplexity is accelerating its push into subscriptions and enterprise sales, signaling a stronger emphasis on monetization as it matures...
Novo Nordisk sues Hims over Wegovy copycat drugs
Novo Nordisk has filed a lawsuit against online telehealth provider Hims & Hers, accusing the company of illegally marketing unapproved and cheaper copies of...
Washington Post Cuts Raise Fears of a “Death Spiral”
The Washington Post’s former executive editor Marty Baron has warned that the newspaper’s future is increasingly uncertain after sweeping layoffs reduced the organization’s scale...
China to Ban Concealed Door Handles on EVs
China is set to become the first country to ban concealed door handles on electric vehicles, responding to mounting safety concerns following several deadly...
Social media giants face jury over teen mental health
A landmark trial begins
For the first time, major social media companies are being forced to defend themselves before a jury over claims that their...